Wolf Theiss Advises Audax Private Equity on Acquisition of Avantor’s Clinical Services business

Prague, 21 August 2024 – Wolf Theiss assisted Audax Private Equity, a leading middle market investment firm based in Boston and San Francisco, with its acquisition of Avantor’s Clinical Services business.

The Wolf Theiss team, working alongside Ropes & Gray LLP, advised Audax Private Equity on all Czech legal and regulatory aspects related to the acquisition of the Clinical Services business, a part of Avantor Inc. Clinical Services provides clinical trial and laboratory supply chain services to pharmaceutical and biotechnology companies, contract research organisations and diagnostic laboratories. The transaction’s value is approximately $650 million.

The transaction team was led by Tereza Naučová (Counsel, Prague) and further included Maroš Kandrík (Associate, Prague), Ondřej Beneš (Counsel, Prague), Tomáš Kren (Counsel, Prague), Kamila Seberová (Counsel, Prague), Michal Matouš (Senior Associate) and Nikola Hnojilová (Associate, Prague).